James McCarter

MD PhD scientist entrepreneur, @BiogeneratorSTL Sr Mg Director, @WUSTL Prof, director at Abbott Lingo, @Virtahealth, founder Divergence & @YSPwustl, 12y keto

[James McCarter @JPMcCarter]

I've been waiting SO LONG to share this STUNNING @virtahealth result. #T2D patients on #keto diet not only reduce WBC & CRP at 2 yrs but also #inflammation markers TNFa, IL-1b, IL-6, -8, -18, INF-g, E,L,P-selectins, EGF, VEGF-A, MCP-1. Controls unchanged https://t.co/vh2JY5ByMg

[James McCarter @JPMcCarter]

I'm now on instagram
https://t.co/gDWW3Rrumz

[James McCarter @JPMcCarter]

I'm now on threads mccarterjim
https://t.co/kXzQOnZuXD

[James McCarter @JPMcCarter]

I'm now on bluesky jmccarter
https://t.co/VtptdvvgzB

[James McCarter @JPMcCarter]

https://t.co/SKIOD025zI

[James McCarter @JPMcCarter]

Several years in the making by our team at Abbott, Lingo CGM is now available in the US. Lingo helps you detect post-meal glucose spikes and determine what foods work best to support your metabolic health https://t.co/rxvTqhrYcV

[James McCarter @JPMcCarter]

At the Health Optimisation Summit, I presented on the impact of glucose in metabolic health. I'm curious to hear your thoughts. What points particularly resonate? What areas need strengthening? I work for Abbott and discuss our Lingo product.
https://t.co/gUAxGgTJfw

[Virta Health @virtahealth]

Through our newest partnership, all @cap_rx customers now have access to Rx Reverse—a high-touch, provider-led, integrated clinical program designed to help members reverse T2D and fight obesity without costly medications.

https://t.co/2g1Cfllo05

[James McCarter @JPMcCarter]

Tech layoffs see former workers in high demand elsewhere - CBS San Francisco https://t.co/tIEcXtjbjZ

[James McCarter @JPMcCarter]

At Abbott, we are continuing to hire tech talent in the bay area including for Lingo, our new biowearables group focused on consumer health & wellness. https://t.co/EpC5qyj88R

[Virta Health @virtahealth]

"I realized a little while ago...I didn't want to die."

Tom is thriving after ~18 months on Virta—down 55 pounds and his A1c has dropped by 2+ points. He's feeling better than ever + excited to watch his kids grow up, and even go skydiving one day!

[Virta Health @virtahealth]

Virta CEO @samiinkinen shares his secret to success—stick to the 'boring' stuff.

"The foundation of long-term success is boring but hard. It’s about sustainable high performance, which is ONLY possible if you take care of your physical and mental health." https://t.co/ECXTEuuvXs

[Dr David Unwin @lowcarbGP]

In 2021 we published our data showing low carb diets can help kidney function here https://t.co/IancpzXZ12 now @virtahealth agree HURRAH !!

[James McCarter @JPMcCarter]

Prior to the development of diabetes or even pre-diabetes, large glucose spikes in response to meals can indicate underlying insulin resistance and hyperinsulinemia.

https://t.co/VlZYhyfSTe

[James McCarter @JPMcCarter]

https://t.co/VlZYhyfSTe

[James McCarter @JPMcCarter]

Glucose response to meals is an important health marker even in a non-diabetes population. My colleagues and I have a new paper in Metabolism reviewing the literature on this important topic.

https://t.co/Ql5KW6idHx

[Eric Sodicoff 👨🏻‍⚕️ @ESodicoffMD]

HUGE NEWS!🗞️Kidney function ⏫improved at two years for patients on Virta compared to 🔽 decline over time in diabetes with usual care.

Virta’s latest research—presented last weekend @ ADA’s 83rd Scientific Sessions.
https://t.co/u0tF5uuCf2

[Virta Health @virtahealth]

Another year, another successful ADA Scientific Sessions!

Recap of Virta's research—on kidney function, sleep, cardiometabolic health and diabetes outcomes for underserved groups—presented at #ADA2023 here: https://t.co/USLeoKYNcA

[Virta Health @virtahealth]

Our newest research out of #ADA2023 shows how Virta is narrowing disparities in T2D care and outcomes. Across the most and least advantaged areas in the US, members are achieving better health (lower A1c, weight loss, & deprescription of Rxs like insulin). https://t.co/Zk6H1px9g9

[Virta Health @virtahealth]

About 1 in 3 people with T2D has chronic kidney disease. New research from #ADA2023 shows Virta’s approach improves kidney function + may slow (or even reverse) progression of this nefarious disease. https://t.co/9WEbvraKkp

[Virta Health @virtahealth]

New research from the Lancet predicts 1.3B+ will have diabetes by 2050, yet GLP-1s aren't the answer.

“The excitement & utility surrounding GLP-1 agonists...is understandable....[but] the solution to unhealthy and unfair societies is not more pills." https://t.co/ckTKgxgzYC